Asia Pacific Anatomic Pathology Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The anatomic pathology market size is expected to reach US$ 14,032.08 million by 2031 from US$ 7,252.84 million in 2023. The market is estimated to record a CAGR of 8.6% from 2023 to 2031.

Executive Summary and Asia Pacific Anatomic Pathology Market Analysis:

China, Japan, India, Australia, and South Korea are among the major countries in the anatomic pathology market in Asia Pacific. The analysis also includes an evaluation of the market in the rest of the countries in the region. The anatomic pathology market growth in this region is ascribed to a rise in the incidence of chronic diseases over the years, and the integration of digital solutions and pathology tools. Moreover, countries such as Australia and South Korea are likely to offer significant growth opportunities to the market players with their continuously advancing healthcare sectors.

Asia Pacific Anatomic Pathology Market Strategic Insights

Get more information on this report Request Free Sample PDF

Asia Pacific Anatomic Pathology Market Segmentation Analysis

Key segments that contributed to the derivation of the anatomic pathology market analysis are product and services, application, and end user.

• Based on product and services, the Asia Pacific anatomic pathology market is segmented into services, instruments, and consumables. The instruments held the largest share of the market in 2023. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.
• By application, the Asia Pacific anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. The disease diagnosis segment held the largest share of the market in 2023.
• By end user, the Asia Pacific anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2023.

Asia Pacific Anatomic Pathology Market Outlook

Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. It helps reduce risks to specimen samples and has the potential to accelerate enrolment in clinical trials. Additionally, digital pathology can reduce sample-to-result turnaround time and streamline the central pathology review process, further offering opportunities to increase trial efficiency.

To introduce upgraded technologies, machine learning (ML) and artificial intelligence (AI) are integrated with digital pathology for proper analysis and management of data. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratory operations to improve the speed and accuracy of processes. With AI and ML, pathologists will have an augmented ability to improve diagnostic accuracy, efficiency, and consistency.

In November 2023, Dedalus Group and Ibex Medical Analytics launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnostics. It enables complete digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) and DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses. The rising focus on integrating AI technology for anatomical pathology processes due to its benefits is expected to act as a trend and is expected to fuel the growth of the market in the forecast period.

Asia Pacific Anatomic Pathology Market Country Insights

Based on country, the Asia Pacific anatomic pathology market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.

In China, cancer has arisen as a significant public health concern affecting the lives of its citizens. According to the World Health Organization (WHO), the country recorded 4.57 million new cancer diagnoses and 3.00 million cancer-related deaths in 2020, ranking first in both these parameters globally. As a result, the emphasis has switched to the early screening, diagnosis, and treatment of cancer cases. In the last two decades, the Chinese central government has launched a series of large-scale cancer screening programs in the form of "transfer payment," such as the "Cancer Screening Program in Rural Areas (2005)," "Cancer Screening Program in Huai River Areas (2007)," "Cervical Cancer and Breast Cancer Screening Program for Women in Rural Areas (2009)," and "Cancer Screening Program in Urban Areas (2012)." These programs have increased population-wide screenings for esophageal, gastric, colorectal, liver, cervical, breast, and other high-risk malignancies. Such strategies contribute significantly to cancer prevention and control in the primary medical facilities throughout China. Furthermore, the country is shifting from traditional pathological diagnosis to digital pathology. According to the China White Paper on Digital Pathology published by the Shanghai Digital Medicine Innovation Center and Beijing-based Equal-Ocean in 2022, 40% of hospitals surveyed are in the process of building or have already established a digital pathology system. More than half of these hospitals have invested over 1 million yuan (US$ 147,620) in digital pathology systems, with some spending more than 5 million yuan each. In addition, the white paper mentioned that ~23% of remote clinical consultations utilized digital pathology in 2022. Thus, with growing investments in the healthcare sector and increasing initiatives for cancer screening, the demand for anatomic pathology tools and digital solutions is rising in China.

Asia Pacific Anatomic Pathology Market Report Highlights

Asia Pacific Anatomic Pathology Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Anatomic Pathology Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Asia Pacific Anatomic Pathology Market Country and Regional Insights